This is the final article in a series.
January 16, 2015—The Government Accountability Office and the Health and Human Services Office of Inspector General is each issuing a report this year on 340B and Medicare – the GAO on how much Medicare spends reimbursing hospitals for 340B-discounted drugs, and the OIG on whether Medicare might save money if it could share in 340B savings.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)